These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 7521738)
1. Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures. Thomson AW; Woo J; Yao GZ; Todo S; Starzl TE; Zeevi A Transpl Immunol; 1993; 1(2):146-50. PubMed ID: 7521738 [TBL] [Abstract][Full Text] [Related]
2. The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis. Woo J; Sewell HF; Thomson AW Scand J Immunol; 1990 Mar; 31(3):297-304. PubMed ID: 1690915 [TBL] [Abstract][Full Text] [Related]
3. Effects of FK 506, mycophenolic acid, and bredinin on OKT-3-, PMA-, and alloantigen-induced activation molecule expression on cultured CD4+ and CD8+ human lymphocytes. Woo J; Zeevi A; Yao GZ; Strednak J; Todo S; Thomson AW Transplant Proc; 1991 Dec; 23(6):2939-40. PubMed ID: 1721319 [No Abstract] [Full Text] [Related]
4. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Eugui EM; Almquist SJ; Muller CD; Allison AC Scand J Immunol; 1991 Feb; 33(2):161-73. PubMed ID: 1826793 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism. Dayton JS; Turka LA; Thompson CB; Mitchell BS Mol Pharmacol; 1992 Apr; 41(4):671-6. PubMed ID: 1569921 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the in vitro and biophysical effects of cyclosporine A, FK-506, and mycophenolic acid on human peripheral blood lymphocytes. Weaver JL; Pine PS; Aszalos A Immunopharmacol Immunotoxicol; 1991; 13(4):563-76. PubMed ID: 1723084 [TBL] [Abstract][Full Text] [Related]
8. [The effect of mycophenolic acid on activation antigen expression and in vitro T lymphocytes proliferation in peripheral blood]. Zheng W; Huang H; Xu C Zhonghua Nei Ke Za Zhi; 2002 May; 41(5):329-32. PubMed ID: 12133428 [TBL] [Abstract][Full Text] [Related]
9. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens. Millán O; Jiménez O; Fortuna V; Barceló JJ; Brunet M Int J Immunopathol Pharmacol; 2006; 19(2):317-30. PubMed ID: 16831299 [TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice. Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187 [TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin. Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315 [No Abstract] [Full Text] [Related]
12. Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium. Lemster B; Woo J; Strednak J; Wang SC; Todo S; Starzl TE; Thomson AW Transplant Proc; 1992 Dec; 24(6):2845-6. PubMed ID: 1281576 [No Abstract] [Full Text] [Related]
13. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics. Gummert JF; Barten MJ; Sherwood SW; van Gelder T; Morris RE J Pharmacol Exp Ther; 1999 Dec; 291(3):1100-12. PubMed ID: 10565830 [TBL] [Abstract][Full Text] [Related]
14. Mycophenolic acid interaction with cyclosporine and tacrolimus in vitro and in vivo: evaluation of additive effects on rat blood lymphocyte function. Barten MJ; Shipkova M; Bartsch P; Dhein S; Streit F; Tarnok A; Armstrong VW; Mohr FW; Oellerich M; Gummert JF Ther Drug Monit; 2005 Apr; 27(2):123-31. PubMed ID: 15795640 [TBL] [Abstract][Full Text] [Related]
15. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis. Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749 [TBL] [Abstract][Full Text] [Related]
16. In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells. Raab M; Daxecker H; Karimi A; Markovic S; Cichna M; Markl P; Müller MM Clin Chim Acta; 2001 Aug; 310(1):89-98. PubMed ID: 11485760 [TBL] [Abstract][Full Text] [Related]
17. Combined immunosuppressive effect of FK 506 and other immunosuppressive agents on PHA- and CD3-stimulated human lymphocyte proliferation in vitro. Jiang H; Suguo H; Takahara S; Takano Y; Li D; Kameoka H; Moutabarrik A; Kokado Y; Ishibashi M; Okuyama A Transplant Proc; 1991 Dec; 23(6):2933-6. PubMed ID: 1721317 [No Abstract] [Full Text] [Related]
18. Impact of mycophenolic acid and tacrolimus on Th17-related immune response. Abadja F; Atemkeng S; Alamartine E; Berthoux F; Mariat C Transplantation; 2011 Aug; 92(4):396-403. PubMed ID: 21818055 [TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells. Nguyen XD; Eichler H; Dugrillon A; Piechaczek C; Braun M; Klüter H J Immunol Methods; 2003 Apr; 275(1-2):57-68. PubMed ID: 12667670 [TBL] [Abstract][Full Text] [Related]
20. Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine. Turka LA; Dayton J; Sinclair G; Thompson CB; Mitchell BS J Clin Invest; 1991 Mar; 87(3):940-8. PubMed ID: 1999502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]